Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.

High TMB is correlated with higher rates of progression and death as compared to low-TMB tumors. These findings may help identify patients who may benefit from alternative treatments, such as immunotherapies.